S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches

Zentalis Pharmaceuticals (ZNTL) SEC Filings & 10K Form

$15.28
+0.37 (+2.48%)
(As of 03/1/2024 ET)

Recent Zentalis Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/29/2024
4:14 PM
Zentalis Pharmaceuticals (Filer)
Form S-3ASR
02/29/2024
4:20 PM
Zentalis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
6:04 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
6:08 AM
Zentalis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
6:43 PM
Avidity Partners Management LP (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2024
7:21 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
7:22 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
7:23 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
7:25 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
7:25 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
7:40 AM
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
02/05/2024
6:11 PM
Blackwell Kimberly (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:12 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:13 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:14 PM
Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:15 PM
Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:16 PM
HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
8:26 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
8:27 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
8:28 PM
Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
8:29 PM
Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
8:29 PM
Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
8:26 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2024
2:26 PM
BlackRock Inc. (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
01/25/2024
6:52 AM
STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
01/25/2024
6:03 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:03 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2024
7:19 PM
Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2024
7:21 PM
Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
4:47 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
4:24 PM
Blackwell Kimberly (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
4:24 PM
Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
8:04 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
8:06 AM
Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2023
2:40 PM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G
10/06/2023
6:18 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
6:19 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
6:19 PM
Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
4:00 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
7:25 PM
Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2023
7:26 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2023
7:28 PM
Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:11 PM
Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
6:00 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
3:09 PM
Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
6:03 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
6:06 AM
Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/20/2023
3:30 PM
Matrix Capital Management Company, LP (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13D/A
06/20/2023
3:30 PM
GOEL DAVID E. (Reporting)
Matrix Capital Management Company, LP (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:19 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
4:01 PM
Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:02 PM
Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:04 PM
Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:23 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
3:12 PM
Zentalis Pharmaceuticals (Filer)
Form 424B5
06/15/2023
6:03 AM
Zentalis Pharmaceuticals (Subject)
Form FWP
06/15/2023
5:02 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
8:10 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
1:24 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
8:37 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2023
8:09 PM
Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
8:10 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
3:34 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/26/2023
11:38 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
6:04 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
6:06 AM
Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2023
6:08 AM
Zentalis Pharmaceuticals (Filer)
Form DEFA14A
05/10/2023
6:11 AM
HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/10/2023
6:13 AM
HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2023
8:07 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2023
3:33 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2023
3:44 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2023
6:11 AM
Zentalis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2023
6:05 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ZNTL) was last updated on 3/2/2024 by MarketBeat.com Staff